Differences and significance of motilin, vasoactive intestinal peptide and gastrin in blood and gallbladder tissues of patients with gallstones

Hepatobiliary and Pancreatic Diseases International

Volumn 7, Issue 1, 2008, Pages 58-64

  Zhang, Zhen Hai ^a   Wu, Shuo Dong ^b   Su, Yang ^b   Jin, Jun Zhe ^b   Fan, Ying ^b   Yu, Hong ^b   Zhang, Li Kui ^b  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^b CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Gallbladder; Gastrin; Motilin; Radioimmunoassay; Vasoactive intestinal peptide

Indexed keywords

GASTRIN; MOTILIN; VASOACTIVE INTESTINAL POLYPEPTIDE;

ADULT; ARTICLE; BILIARY EXCRETION; CHOLELITHIASIS; CLINICAL ARTICLE; COMMON BILE DUCT STONE; CONTROLLED STUDY; FEMALE; GALLBLADDER; GALLBLADDER DISEASE; GALLBLADDER DYSMOTILITY; GALLSTONE; GASTROINTESTINAL SYMPTOM; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; POLYPOSIS; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY;

COMMON BILE DUCT; FEMALE; GALLBLADDER; GALLSTONES; GASTRINS; GASTROINTESTINAL HORMONES; HUMANS; MALE; MIDDLE AGED; MOTILIN; POLYPS; VASOACTIVE INTESTINAL PEPTIDE;

EID: 39049121634     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Rehfeld JF, Friis-Hansen L, Goetze JP, Hansen TV. The biology of cholecystokinin and gastrin peptides. Curr Top Med Chem 2007;7:1154-1165.
2. Vu MK, Van Oostayen JA, Biemond I, Masclee AA. Effect of somatostatin on postprandial gallbladder relaxation. Clin Physiol 2001;21:25-31.
3. Zhou W, Yang JQ, Wen YY, Wang DK, Xu YQ, Jin SL. Changes and its significance of motilin, vasoactive intestinal peptide in plasma, gallbladder tissues and bile in patients with gallstone disease. Chin J Bases Clin Gen Surg 2001;8:171-172,186.
4. Montet JC, Caroli-Bosc FX, Ferrari P, Piche T, Baize N, Anty R, et al. Gallbladder motility and gut hormone plasma levels in subjects with and without gallstones. Gastroenterol Clin Biol 2005;29:569-572.
5. Jin SL, Yang YZ, Su H, Yu CH, Hua YW. The change and significance of serum motilin in patients with gallbladder stones. Chin J Exp Surg 1995;12:344-345.
6. Kamerling IM, Van Haarst AD, De Kam ML, Cohen AF, Masclee AA, Burggraaf J. Gallbladder volume as a biomarker for the motilin effect in healthy volunteers and patients with functional dyspepsia. Aliment Pharmacol Ther 2004;19:797-804.
7. Luiking YC, Akkermans LM, van der Reijden AC, Peeters TL, van Berge-Henegouwen GP. Differential effects of motilin on interdigestive motility of the human gastric antrum, pylorus, small intestine and gallbladder. Neurogastroenterol Motil 2003;15:103-111.
8. Acalovschi M, Dumitrascu DL, Hagiu C. Oral clarithromycin enhances gallbladder emptying induced by a mixed meal in healthy subjects. Eur J Intern Med 2002;13:104-107.
9. Sengupta S, Modak P, McCauley N, O'Donnell LJ. Effect of oral clarithromycin on gall-bladder motility in normal subjects and those with gall-stones. Aliment Pharmacol Ther 2006;24:95-99.
10. Portincasa P, Altomare DF, Moschetta A, Baldassarre G, Di Ciaula A, Venneman NG, et al. The effect of acute oral erythromycin on gallbladder motility and on upper gastrointestinal symptoms in gastrectomized patients with and without gallstones: a randomized, placebo-controlled ultrasonographic study. Am J Gastroenterol 2000;95: 3444-3451.
11. Saccone GT, Liu YF, Thune A, Harvey JR, Baker RA, Toouli J. Erythromycin and motilin stimulate sphincter of Oddi motility and inhibit trans-sphincteric flow in the Australian possum. Naunyn Schmiedebergs Arch Pharmacol 1992;346:701-706.
12. Behar J, Biancani P. Effects and mechanisms of action of motilin on the cat sphincter of Oddi. Gastroenterology 1988;95:1099-1105.
13. Muller EL, Grace PA, Conter RL, Roslyn JJ, Pitt HA. Influence of motilin and cholecystokinin on sphincter of Oddi and duodenal mobility. Am J Physiol 1987;253:G679-683.
14. Baker RA, Saccone GT, Costi D, Thune A, Toouli J. Motilin and erythromycin enhance the in vitro contractile activity of the sphincter of Oddi of the Australian brush-tailed possum. Naunyn Schmiedebergs Arch Pharmacol 1992; 345:71-77.
15. Nielsen KG, Bomgren P, Holmgren S, Johnsen AH. Gastrin and cholecystokinin of the bullfrog, Rana catesbeiana, have distinct effects on gallbladder motility and gastric acid secretion in vitro. Gen Comp Endocrinol 1998;112: 247-254.
16. Ruckebusch Y, Soldani G. Gallbladder motility in sheep: effects of cholecystokinin and related peptides. J Vet Pharmacol Ther 1985;8:263-269.
17. Chen XX, Mo JZ, Liu WZ. A study on motility of sphincter of Oddi in postcholecystectomy syndrome. Zhonghua Nei Ke Za Zhi 1991;30:337-339, 381.
18. El-Salhy M, Stenling R, Grimelius L. Peptidergic innervation of the human gallbladder. Ups J Med Sci 1996; 101:87-96.
19. Talmage EK, Pouliot WA, Schemann M, Mawe GM. Structure and chemical coding of human, canine and opossum gallbladder ganglia. Cell Tissue Res 1996;284:289-302.
20. Meedeniya AC, Schloithe AC, Toouli J, Saccone GT. Characterization of the intrinsic and extrinsic innervation of the gall bladder epithelium in the Australian Brush-tailed possum (Trichosurus vulpecula). Neurogastroenterol Motil 2003;15:383-392.
21. Greaves RR, O'Donnell LJ, Battistini B, Forget MA, Farthing MJ. The differential effect of VIP and PACAP on guinea pig gallbladder in vitro. Eur J Gastroenterol Hepatol 2000;12:1181-1184.
22. Kalfin R, Milenov K. The effect of vasoactive intestinal polypeptide (VIP) on the canine gallbladder motility. Comp Biochem Physiol C 1991;100:513-517.
23. Chen Q, Amaral J, Oh S, Biancani P, Behar J. Gallbladder relaxation in patients with pigment and cholesterol stones. Gastroenterology 1997;113:930-937.
24. Alcón S, Morales S, Camello PJ, Salido GM, Miller SM, Pozo MJ. Relaxation of canine gallbladder to nerve stimulation involves adrenergic and non-adrenergic non-cholinergic mechanisms. Neurogastroenterol Motil 2001; 13:555-566.
25. Bjorck S, Fahrenkrug J, Jivegard L, Svanvik J. Release of immunoreactive vasoactive intestinal peptide (VIP) from the gallbladder in response to vagal stimulation. Acta Physiol Scand 1986;128:639-642.
26. Nilsson B, Delbro D, Thune A, Friman S, Jivegard L, Svanvik J. VIP-antiserum and indomethacin inhibit calcium and bicarbonate secretion by the inflamed feline gallbladder mucosa. Acta Physiol Scand 1996;158:203-209.
27. Nilsson B, Delbro D, Friman S, Thune A, Svanvik J. Sympathetic and VIP-ergic control of calcium and bicarbonate transport in the feline gall bladder mucosa in vivo. J Auton Nerv Syst 1996;60:49-55.
28. Nilsson B, Friman S, Thune A, Jivegard L, Svanvik J. Inflammation reduces mucosal secretion of hydrogen ions and impairs concentrating function and luminal acidification in feline gallbladder. Scand J Gastroenterol 1995;30:1021-1026.
29. Fu HQ, Jiang XQ, Xiong BJ, Tan ZT, Zou SB, Hu ZQ. Study on somatostatin and vasoactive intestinal peptide in guinea pig during gallstone formation. Chin J Exp Surg 2000;17:28-29.
30. Gao G, Ding ZQ, Zou SQ. The changes of vasoactive intestinal polypeptide and VIPR expression in the patients with cholesterol gallstone. J Clin Surg 2004;12:224-226.
31. Zhang ZH, Wu SD, Gao H, Shi G, Jin JZ, Kong J, et al. Expression of pituitary adenylate cyclase-activating polypeptide 1 and 2 receptor mRNA in gallbladder tissue of patients with gallstone or gallbladder polyps. World J Gastroenterol 2006;12:1468-1471.
32. Simula ME, Brookes SJ, Meedeniya AC, Toouli J, Saccone GT. Distribution of nitric oxide synthase and vasoactive intestinal polypeptide immunoreactivity in the sphincter of Oddi and duodenum of the possum. Cell Tissue Res 2001;304:31-41.
33. Pálvolgyi A, Sári R, Németh J, Szabolcs A, Nagy I, Hegyi P, et al. Interplay between nitric oxide and VIP in CCK-8-induced phasic contractile activity in the rabbit sphincter of Oddi. World J Gastroenterol 2005;11:3264-3266.
34. Kuo YL, Chiu JH, Lin JG, Hsieh CL, Wu CW. Localization of cholecystokinin and vasoactive intestinal peptide in lower biliary tract in cats following electroacupuncture on right Qimen (LR14) and Riyue (GB 24): an immunohistochemistry study. Acupunct Electrother Res 2005;30:15-25.